Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 1
2012 2
2013 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression.
Masu T, Atsukawa M, Nakatsuka K, Shimizu M, Miura D, Arai T, Harimoto H, Kondo C, Kaneko K, Futagami S, Kawamoto C, Takahashi H, Iwakiri K. Masu T, et al. Among authors: harimoto h. PLoS One. 2018 Dec 31;13(12):e0200664. doi: 10.1371/journal.pone.0200664. eCollection 2018. PLoS One. 2018. PMID: 30596643 Free PMC article.
Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y, Kanazawa H, Taki Y, Kimura Y, Atsukawa M, Katakura T, Kidokoro H, Harimoto H, Fukuda T, Matsushita Y, Nakatsuka K, Sakamoto C. Narahara Y, et al. Among authors: harimoto h. J Gastroenterol Hepatol. 2009 Nov;24(11):1791-7. doi: 10.1111/j.1440-1746.2009.05873.x. Epub 2009 Aug 3. J Gastroenterol Hepatol. 2009. PMID: 19686420 Clinical Trial.
Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial.
Narahara Y, Kanazawa H, Fukuda T, Matsushita Y, Harimoto H, Kidokoro H, Katakura T, Atsukawa M, Taki Y, Kimura Y, Nakatsuka K, Sakamoto C. Narahara Y, et al. Among authors: harimoto h. J Gastroenterol. 2011 Jan;46(1):78-85. doi: 10.1007/s00535-010-0282-9. Epub 2010 Jul 15. J Gastroenterol. 2011. PMID: 20632194 Clinical Trial.